India has signed an agreement with Egypt’s Eva Pharma company for drugs and medical supplies to buy …
Remdesivir
-
-
FeatureIndustry & TradeTech/AI
Egypt’s Eva Pharma to export 1st batch of coronavirus treatment Favipiravir
by Sanaa Allamby Sanaa AllamEgyptian drug-maker, Eva Pharma, is ready to start exporting “Favipiravir” an anti-viral compound that has proven to …
-
The European Union’s executive said it has signed a contract with Gilead for its COVID-19 medicine remdesivir …
-
FeatureIndustry & TradeTech/AI
Eva Pharma doubles antibiotics, blood clotting drugs production to help in treating Covid-19
by Sanaa Allamby Sanaa AllamEgypt-based Eva Pharma, manufacturing and sale of remdesivir, said that the company has doubled the production capacity …
-
Egypt is developing four vaccines that have been registered by the World Health Organisation (WHO) to treat …
-
Gilead Sciences Inc priced its COVID-19 antiviral remdesivir at $2,340 per patient for wealthier nations and agreed …
-
Gilead Sciences Inc, which makes the antiviral drug remdesivir and is now testing it for potential coronavirus …
-
FeatureIndustry & TradeTech/AI
Egypt’s drug maker, Eva Pharma to manufacture Gilead’s remdesivir for coronavirus treatment
by Sanaa Allamby Sanaa AllamEgypt-based Eva Pharma has signed a deal with Gilead Sciences for manufacturing and sale of remdesivir, which …
-
Industry & TradeTech/AI
Gilead’s Remdesivir study on monkeys shows drug reduced lung damage linked to coronavirus
Gilead Sciences’ antiviral drug remdesivir has helped to prevent macaques infected with the coronavirus from developing respiratory …
-
Industry & TradeTech/AI
AstraZeneca is approaching Gilead about a potential merger – the healthcare deal on record
UK drugmaker AstraZeneca has approached Gilead about a potential merger, a healthcare deal that is expected to …